| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Department of Neurology and Epilepsy Center (Dr. Crino), University of Pennsylvania Medical Center; and the Department of Medical Oncology (Dr. Henske), Fox Chase Cancer Center, Philadelphia, PA.
Address correspondence and reprint requests to Dr. Peter B. Crino, Department of Neurology and Epilepsy Center, University of Pennsylvania Medical Center, 3 West Gates Bldg., 3400 Spruce St., Philadelphia, PA 19104.
OBJECTIVE: To outline recent developments in the neurobiology of the tuberous sclerosis complex (TSC).
BACKGROUND: TSC may be associated with neuropsychiatric disorders including epilepsy, mental retardation, and autism. The uncontrolled growth of subependymal giant cell astrocytomas may lead to hydrocephalus and death. The recent identification of mutations in two genes (TSC1 and TSC2) that cause TSC has led to rapid progress in understanding the molecular and cellular pathogenesis of this disorder. How distinct mutations lead to the varied clinical phenotype of TSC is under intense investigation.
RESULTS: We report the recent diagnostic criteria for TSC and provide an overview of the molecular genetics, molecular pathophysiology, and neuropathology of TSC. Important diagnostic criteria for TSC include facial angiofibromas, ungual fibromas, retinal hamartomas, and cortical tubers. Both familial and sporadic TSC cases occur. Approximately 50% of TSC families show genetic linkage to TSC1 and 50% to TSC2. Among sporadic TSC cases, mutations in TSC2 are more frequent and often accompanied by more severe neurologic deficits. Multiple mutational subtypes have been identified in the TSC1 and TSC2 genes. The TSC1 (chromosome 9) and TSC2 (chromosome 16) genes encode distinct proteins, hamartin and tuberin, respectively, which are widely expressed in the brain and may interact as part of a cascade pathway that modulates cellular differentiation, tumor suppression, and intracellular signaling. Tuberin has a GTPase activating protein–related domain that may contribute to a role in cell cycle passage and intracellular vesicular trafficking.
CONCLUSION: Identification of tuberous sclerosis complex (TSC) gene mutations has fostered understanding of how brain lesions in TSC are formed. Further characterization of the roles of hamartin and tuberin will provide potential therapeutic avenues to treat seizures, mental retardation, and tumor growth in TSC.
Key words: Neurobiology—Tuberous sclerosis complex—Mutations.
This article has been cited by other articles:
|
|
 |
|
  E. A. Goncharova, D. A. Goncharov, P. N. Lim, D. Noonan, and V. P. Krymskaya Modulation of Cell Migration and Invasiveness by Tumor Suppressor TSC2 in Lymphangioleiomyomatosis Am. J. Respir. Cell Mol. Biol., April 1, 2006; 34(4): 473 - 480. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Wong Study of the Relationship Between Tuberous Sclerosis Complex and Autistic Disorder J Child Neurol, March 1, 2006; 21(3): 199 - 204. [Abstract] [PDF]
|
|
|
|
|
|
J. J. Collins, C. Tudor, J. M. Leonard, G. Chuck, and D. N. Franz Levetiracetam as Adjunctive Antiepileptic Therapy for Patients with Tuberous Sclerosis Complex: A Retrospective Open-Label Trial J Child Neurol, January 1, 2006; 21(1): 53 - 57. [Abstract] [PDF]
|
|
|
|
 |
|
 E. Goncharova, D. Goncharov, D. Noonan, and V. P. Krymskaya TSC2 modulates actin cytoskeleton and focal adhesion through TSC1-binding domain and the Rac1 GTPase J. Cell Biol., December 20, 2004; 167(6): 1171 - 1182. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Goh, W. Butler, and E. A. Thiele Subependymal giant cell tumors in tuberous sclerosis complex Neurology, October 26, 2004; 63(8): 1457 - 1461. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. Roach and S. P. Sparagana Diagnosis of Tuberous Sclerosis Complex J Child Neurol, September 1, 2004; 19(9): 643 - 649. [Abstract] [PDF]
|
|
|
|
|
|
F. J. DiMario JR Brain Abnormalities in Tuberous Sclerosis Complex J Child Neurol, September 1, 2004; 19(9): 650 - 657. [Abstract] [PDF]
|
|
|
|
|
|
P. B. Crino Molecular Pathogenesis of Tuber Formation in Tuberous Sclerosis Complex J Child Neurol, September 1, 2004; 19(9): 716 - 725. [Abstract] [PDF]
|
|
|
|
 |
|
 F. G. Garaci, R. Floris, A. Bozzao, G. Manenti, A. Simonetti, T. Lupattelli, P. Curatolo, and G. Simonetti Increased Brain Apparent Diffusion Coefficient in Tuberous Sclerosis Radiology, August 1, 2004; 232(2): 461 - 465. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Birchenall-Roberts, T. Fu, O.-s. Bang, M. Dambach, J. H. Resau, C. L. Sadowski, D. C. Bertolette, H.-J. Lee, S.-J. Kim, and F. W. Ruscetti Tuberous Sclerosis Complex 2 Gene Product Interacts with Human SMAD Proteins: A MOLECULAR LINK OF TWO TUMOR SUPPRESSOR PATHWAYS J. Biol. Chem., June 11, 2004; 279(24): 25605 - 25613. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Abel, D. T. Brockbank, M. Farber, and D. R. Meyer Bony Hamartoma of the Inferior Orbital Rim in a Patient With Tuberous Sclerosis Arch Ophthalmol, May 1, 2004; 122(5): 780 - 782. [Full Text] [PDF]
|
|
|
|
 |
|
 F di Michele, M Verdecchia, M Dorofeeva, L Costamagna, G Bernardi, P Curatolo, and E Romeo GABAA receptor active steroids are altered in epilepsy patients with tuberous sclerosis J. Neurol. Neurosurg. Psychiatry, May 1, 2003; 74(5): 667 - 670. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. P. Krymskaya and J. M. Shipley Lymphangioleiomyomatosis: A Complex Tale of Serum Response Factor-Mediated Tissue Inhibitor of Metalloproteinase-3 Regulation Am. J. Respir. Cell Mol. Biol., May 1, 2003; 28(5): 546 - 550. [Full Text] [PDF]
|
|
|
|
|
|
M. T. Mackay, L. E. Becker, S. H. Chuang, H. Otsubo, N. A. Chuang, J. Rutka, B. Ben-Zeev, O. C. Snead III, and S. K. Weiss Malformations of cortical development with balloon cells: Clinical and radiologic correlates Neurology, February 25, 2003; 60(4): 580 - 587. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Li, K. Inoki, R. Yeung, and K.-L. Guan Regulation of TSC2 by 14-3-3 Binding J. Biol. Chem., November 15, 2002; 277(47): 44593 - 44596. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. D. Morton, A. F. Youssef, E. Lloyd, A. L. Kiorpes, T. L. Goldsworthy, and F. L. Fort Evaluation of Carcinogenic Responses in the Eker Rat following Short-Term Exposure to Selected Nephrotoxins and Carcinogens Toxicol Pathol, August 1, 2002; 30(5): 559 - 564. [Abstract] [PDF]
|
|
|
|
 |
|
 W. Mukonoweshuro, I. D. Wilkinson, and P. D. Griffiths Proton MR Spectroscopy of Cortical Tubers in Adults with Tuberous Sclerosis Complex AJNR Am. J. Neuroradiol., November 1, 2001; 22(10): 1920 - 1925. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Kyin, Y. Hua, M. Baybis, B. Scheithauer, D. Kolson, E. Uhlmann, D. Gutmann, and P. B. Crino Differential Cellular Expression of Neurotrophins in Cortical Tubers of the Tuberous Sclerosis Complex Am. J. Pathol., October 1, 2001; 159(4): 1541 - 1554. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
